Dow Jones 30 Stocks SEC Filings — November 04, 2026

USA Dow Jones 30

By Gunpowder Editorial ·

10 high priority 1 medium priority 11 total filings analysed

Executive Summary

This digest of 11 Dow Jones 30 filings reveals a deeply mixed picture for Q3 2026. While top-line growth is evident across industrials (Caterpillar +21% sales, 42.9% profit jump) and pharma (Amgen +8.5% revenue, +20.1% net income), significant headwinds are building.

Consumer-facing companies like McDonald's are showing strain with negative U.S. comparable sales, and Merck is experiencing a dramatic profit collapse due to a massive $13.8B R&D asset acquisition charge. The most material event is 3M's $7.35B PFAS settlement, a high-impact liability that introduces multi-year financial drag. Insider trading activity is uniformly bearish, with high-level executives at Coca-Cola, Sherwin-Williams, Chevron, and Amazon all cashing out significant equity, signaling a lack of conviction at the top. Capital allocation is mixed, with Caterpillar's strong operational performance offset by a $4.1B inventory build and a $129M comprehensive income loss. The portfolio-level trend is one of 'growth at a cost'—revenue expansion is being consumed by rising expenses, legal liabilities, and insider skepticism, creating a cautious outlook for the near term.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K · 10-Q · Form 4

Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from November 03, 2026.

Investment Signals (10)

  • Profit surged 42.9% YoY on 21% revenue growth, the strongest operational performance in the cohort. However, cash fell 20.6% and inventory built $4.1B, signaling growth is capital-intensive [BULLISH/BEARISH]

  • Amgen Inc ↓ (BULLISH)
    ▲

    Net income rose 20.1% YoY on 8.5% revenue growth, showing strong operating leverage. R&D spending increased 11.1%, a positive signal for future pipeline, but other income fell 49.1% over nine months

  • ▲

    EVP Perez Beatriz R sold 30,681 shares for ~$2.91M after exercising options at a deep discount ($45.44 vs $94.84 sale price). This is a clear profit-taking event from a top executive, signaling a potential peak in valuation sentiment

  • ▲

    President of New Energies GUSTAVSON JE B sold 24,439 shares (~$5.64M), reducing holdings to just 3,818 shares. The near-total liquidation of his position is a strong bearish signal on the company's future prospects from an insider

  • 3M Co ↓ (MIXED)
    ▲

    The $7.35B PFAS settlement is a massive liability but provides legal closure. The pre-tax charge in Q4 2026 creates a one-time earnings headwind, but the removal of litigation overhang could be a long-term positive if the market views it as a 'cleaning of the books'

  • ▲

    Nine-month net income swung to a loss of $510M from a prior-year profit of $15.3B, driven by a $13.8B R&D acquisition charge. This is a massive earnings destroyer, but if the acquired assets deliver, it could be a 'buy-the-dip' opportunity

  • Issued $25.25B in new debt across ten tranches (2028-2066). This massive capital raise signals aggressive investment plans (likely AI infrastructure), but the sheer size ($25B+) increases interest rate risk and leverage [BULLISH/BEARISH]

  • McDonald's Corp (BEARISH)
    ▲

    U.S. comparable sales declined 0.2% despite a value intervention, and total revenue grew only 1%. This is a warning sign for the company's ability to drive same-store growth in its largest market, even with promotional spending

  • ▲

    CEO of Worldwide Amazon Stores sold 1,000 shares under a Rule 10b5-1 plan. While a small trade, the use of a pre-arranged plan by a top retail executive suggests a desire to avoid insider trading scrutiny, a neutral-to-slightly-bearish signal

  • SVP & CLO GARCEAU MARY L sold 3,891 shares (~$1.36M). The sale by the Chief Legal Officer, who is privy to litigation and regulatory risks, is a notable bearish signal on the company's legal outlook

Risk Flags (10)

  • The $7.35B PFAS settlement (present value $5.8B) is a multi-year financial overhang. While not an admission of liability, the $5.8B pre-tax charge in Q4 2026 will severely impact near-term earnings and free cash flow

  • Nine-month net income swung to a loss of $510M from a $15.3B profit. The $13.8B R&D asset acquisition charge is a massive value-destroying event that has obliterated the company's earnings base for the year

  • Cash and equivalents fell 20.6% to $7.9B despite a 42.9% profit jump. The $4.1B inventory build and $3.8B receivables increase indicate the profit growth is being consumed by working capital needs, a classic red flag for earnings quality

  • McDonald's / U.S. Comparable Sales Decline [HIGH RISK]
    ▼

    A 0.2% decline in U.S. comparable sales, even with a value intervention, is a critical warning for the company's core market. Negative guest counts suggest the brand is losing relevance or facing pricing pressure

  • ▼

    The President of New Energies sold nearly all his shares, leaving only 3,818. This is a massive vote of no confidence from the leader of a key strategic growth division (New Energies)

  • The EVP exercised options at $45.44 and immediately sold at $94.84, pocketing a ~$1.5M profit. This pattern of 'exercise and sell' by a top executive is a strong signal they believe the stock is fairly valued or overvalued

  • The allowance for credit losses increased 17% to $332M, even as write-offs declined. This suggests the company is anticipating a deterioration in its loan portfolio, a leading indicator for credit stress in the industrial sector

  • Koselugo alliance revenue fell 94% YoY to just $13M. This is a near-total loss of a revenue stream, highlighting the volatility of partnership-dependent income

  • ▼

    The $25.25B debt issuance is the largest single capital markets event in this digest. While it signals investment, it also adds significant leverage and interest expense, making the company more sensitive to rate changes

  • The SVP & CLO sold ~$1.36M in stock. The sale by the top legal officer is a specific risk flag, as it may indicate knowledge of upcoming litigation, regulatory, or compliance issues

Opportunities (8)

  • ◆

    With net income up 20.1% YoY and R&D spending rising 11.1%, Amgen is showing strong operating leverage while investing in the future. The improved accumulated deficit ($19.8B from $25.1B) suggests a path to balance sheet normalization

  • The 42.9% profit jump on 21% revenue growth is a powerful cyclical signal. If the inventory build is a strategic bet on demand (not a demand miss), the company is positioned for a strong 2027 as the working capital cycle turns

  • ◆

    The PFAS settlement, while costly, removes a decade-long overhang. For investors who believe the market has over-penalized 3M, the resolution could unlock a re-rating catalyst as the company's 'clean' earnings become visible

  • The $25.25B debt raise is a massive bet on future growth, likely tied to AI and cloud infrastructure. For investors bullish on the AI capex cycle, this signals Microsoft is going 'all in', creating a potential first-mover advantage

  • McDonald's / Value Intervention Recovery (OPPORTUNITY)
    ◆

    Management noted improvement in U.S. comparable sales as the quarter progressed following its value intervention. If this trend holds, Q4 could show a recovery, creating a 'buy the dip' opportunity on the current weakness

  • Total finance receivables expanded 14% to $36.3B, driving a 56% increase in comprehensive income ($189M vs $121M). This is a strong signal of demand for equipment financing, a leading indicator for Caterpillar's core business

  • The massive $13.8B charge is a one-time event. If the acquired R&D assets generate pipeline value, the current earnings collapse could be a 'kitchen sink' moment, creating a deep value entry point for long-term investors

  • ◆

    The CEO's sale of only 1,000 shares (out of 474,681 held) under a 10b5-1 plan is a non-event. The massive retained holdings signal management's long-term conviction, a positive contrast to the insider flight at Chevron and Coca-Cola

Sector Themes (6)

  • Industrial Cyclical Strength
    ◆

    Caterpillar and Caterpillar Financial are showing powerful cyclical upswings, with 42.9% and 8% profit growth respectively. This suggests a strong capital equipment replacement cycle is underway, driven by infrastructure and energy demand.

  • Insider Cash-Out Across Sectors
    ◆

    A clear pattern of insider selling is visible across consumer (Coca-Cola), industrial (Sherwin-Williams), energy (Chevron), and retail (Amazon). This broad-based profit-taking suggests a top-of-market sentiment among corporate insiders, a contrarian signal to the operational strength seen in some filings.

  • Consumer Stagnation vs. Industrial Growth
    ◆

    McDonald's (1% revenue growth) is a stark contrast to Caterpillar (21% revenue growth). This divergence highlights a 'K-shaped' recovery where industrial and capital goods companies are booming while consumer-facing companies struggle with volume and pricing power.

  • The Cost of Legal Closure
    ◆

    3M's $7.35B settlement is a high-profile example of a company paying to move past a legacy liability. This theme is likely to be a growing feature of the Dow 30 landscape as companies face PFAS, opioid, and other mass tort litigations.

  • Growth Consumed by Working Capital
    ◆

    Caterpillar's 42.9% profit jump is being partially consumed by a $4.1B inventory build and $3.8B receivables increase. This pattern suggests that even strong operational growth may not translate to free cash flow, a key risk for dividend and buyback sustainability.

  • Massive Debt as a Strategic Signal
    ◆

    Microsoft's $25.25B debt issuance is the largest single capital markets event in this cohort. It signals a shift from 'cash-rich' tech to 'debt-financed investment', a structural change that will define the company's risk profile for the next decade.

Watch List (8)

  • The $5.8B pre-tax charge for the PFAS settlement will be recorded in Q4 2026. The earnings call will be critical to understand the cash flow impact and any changes to the 2026 guidance. Watch for guidance cuts.

  • The $4.1B inventory build and $3.8B receivables increase need to be monitored for signs of demand softening or channel stuffing. The Q4 call will reveal if the working capital cycle is turning or worsening.

  • The $13.8B acquisition charge is a one-time event, but the performance of the acquired assets will determine if the earnings collapse was a 'kitchen sink' or a value destroyer. Watch for pipeline updates in Q4.

  • The President's near-total share liquidation is a massive red flag for the New Energies division. Watch for any restructuring, divestiture, or strategic pivot announcements in the coming quarters.

  • McDonald's / Q4 2026 U.S. Comparable Sales
    👁

    Management cited improvement in Q3 after a value intervention. Q4 results will be the proof point. A continued decline would signal a structural issue in the U.S. market, while a recovery would validate the strategy.

  • The EVP's profit-taking may be a one-off, but if other C-suite executives follow suit, it would signal a broader loss of confidence. Watch for Form 4 filings from other top officers.

  • The filing does not disclose the use of proceeds for the $25.25B debt. Watch for any M&A, dividend, or capex announcements that clarify the purpose of this massive capital raise.

  • The 17% increase in the allowance for credit losses is a leading indicator. Watch for any rise in actual write-offs in Q4 2026, which would confirm a deterioration in credit quality.

Filing Analyses (11)
MCDONALDS CORP 8-K mixed materiality 8/10

04-11-2026

McDonald's reported Q3 2026 results with Systemwide sales up 4% to over $38 billion and consolidated operating income up 7% (8% excluding restructuring charges). Diluted EPS rose 10% to $3.51, while U.S. comparable sales slipped 0.2% and total revenues grew only 1%. The quarter shows mixed performance: strong international growth and earnings expansion offset by a U.S. comparable sales decline and weak top-line revenue growth.

  • · U.S. comparable sales declined 0.2%, with negative guest counts partly offset by positive check growth, though management cited improvement as the quarter progressed following its value intervention
  • · France was a drag on International Operated Markets comparable sales, and China was negative within International Developmental Licensed Markets
  • · Q3 revenue growth of just 1% (1% in constant currency) lagged Systemwide sales growth of 4%, as franchised-driven revenue gains were partly offset by a 3% decline in Company-operated restaurant sales
  • · Q3 operating income benefited from a $102M increase in Other operating income, net, which contributed meaningfully to the 7% growth
  • · Nine-month SG&A expenses rose 9% in Other SG&A, partly offsetting operating income gains
  • · Nonoperating income swung from $75M income in 9M 2025 to $4M expense in 9M 2026
AMGEN INC 10-Q mixed materiality 8/10

04-11-2026

Amgen reported Q3 2026 total revenues of $10,365 Million, up 8.5% YoY from $9,557 Million, with net income of $3,864 Million (up 20.1% YoY) and diluted EPS of $7.08 (up 19.4% from $5.93). Nine-month revenues reached $29,037 Million (up 8.0%) and net income $8,058 Million (up 26.3%). Performance was mixed: Q3 cost of sales and SG&A declined, but R&D spending rose 11.1% and Other income, net fell 21.7% YoY in the quarter, while nine-month Other income, net dropped 49.1%.

  • · Q3 2026 Other operating expense fell sharply to $76 Million from $329 Million, a 76.9% decline.
  • · Total assets rose to $96,048 Million from $90,586 Million at December 31, 2025, while intangible assets declined to $19,536 Million from $22,276 Million.
  • · Accumulated deficit improved to $(19,807) Million from $(25,107) Million at year-end 2025.
  • · Current portion of long-term debt fell to $2,398 Million from $4,599 Million, and cash rose to $13,190 Million from $9,129 Million.
  • · Q3 2026 comprehensive income of $3,858 Million rose 15.6% YoY from $3,338 Million, though Q3 OCI turned negative at $(6) Million versus $122 Million a year earlier.
3M CO 8-K mixed materiality 10/10

04-11-2026

3M has entered a broad settlement resolving PFAS-related personal injury claims in the AFFF Multi-District Litigation, committing a pre-tax $7.35 billion nominal ($5.8 billion present value) over nine years, with a $5.8 billion pre-tax charge to be recorded in Q4 2026. The company states the settlement is not an admission of liability and does not change its previously issued 2026 guidance, which is treated as a special item in adjusted results.

  • · Settlement follows a 2023 resolution with U.S. public water suppliers and a more recent settlement with the State of New Jersey
  • · 3M announced in 2022 it would discontinue manufacture of all PFAS globally by end of 2025 and states it met that goal
  • · Settlement payments are contingent on plaintiffs joining the resolution, and an anticipated MDL court order would set evidentiary and timing requirements for future claims
  • · If certain agreed settlement terms are not fulfilled, 3M is prepared to continue defending itself in litigation
  • · Investor teleconference scheduled for 8:30 a.m. ET on November 4, 2026
CATERPILLAR FINANCIAL SERVICES CORP 10-Q mixed materiality 5/10

04-11-2026

Caterpillar Financial Services Corp reported Q3 2026 comprehensive income of $189M versus $121M in Q3 2025, and profit of consolidated companies rose 8% YoY to $145M from $134M. Year-to-date profit grew 8% to $434M from $402M, while total finance receivables expanded 14% to $36.3B and total assets reached $41.4B. However, the quarter's customer write-offs rose to $46M from $52M in prior-year Q3 (a decline) while the allowance for credit losses increased 17% to $332M, and foreign currency translation was negative for the nine-month period (-$24M versus +$306M in the prior year), signaling mixed performance.

  • · Retained earnings rose to $3,786M from $3,352M at December 31, 2025
  • · Total shareholder's equity increased to $3,694M from $3,227M
  • · Short-term borrowings declined to $4,855M from $5,514M while long-term debt rose to $21,552M from $20,018M
  • · Nine-month provision for credit losses rose 60% to $138M from $82M
  • · 91+ days past due receivables total $178M across portfolios
  • · Cash, cash equivalents and restricted cash at period end was $664M versus $731M a year earlier
COCA COLA CO 4 negative materiality 7/10

04-11-2026

Executive Vice President Perez Beatriz R sold 30,681 Common Stock, $.25 Par Value at $94.84 (~$2.91M). 9 transactions reported in total. Perez Beatriz R holds 160,428 shares after the transaction.

  • · Executive Vice President Perez Beatriz R exercised/converted 30,681 Common Stock, $.25 Par Value at $45.44 (~$1.39M)
  • · Executive Vice President Perez Beatriz R sold 30,681 Common Stock, $.25 Par Value at $94.84 (~$2.91M)
  • · Executive Vice President Perez Beatriz R exercised/converted 10,000 Common Stock, $.25 Par Value at $59.49 (~$595K)
  • · Executive Vice President Perez Beatriz R sold 10,000 Common Stock, $.25 Par Value at $94.84 (~$948K)
  • · Executive Vice President Perez Beatriz R exercised/converted 26,867 Common Stock, $.25 Par Value at $59.49 (~$1.6M)
  • · Executive Vice President Perez Beatriz R sold 26,867 Common Stock, $.25 Par Value at $95.02 (~$2.55M)
  • · Executive Vice President Perez Beatriz R exercised/converted 30,681 Employee Stock Option (Right to Buy)
  • · Executive Vice President Perez Beatriz R exercised/converted 10,000 Employee Stock Option (Right to Buy)
MICROSOFT CORP 8-K neutral materiality 6/10

04-11-2026

Microsoft Corporation entered into an Underwriting Agreement dated October 29, 2026 to issue and sell a total of $25.25 billion aggregate principal amount of senior unsecured notes across ten tranches maturing between 2028 and 2066, issued under a Sixteenth Supplemental Indenture dated November 4, 2026. The filing discloses pricing structure and maturities but does not disclose the aggregate proceeds' use or any financial performance metrics, so it contains no period-over-period comparison.

  • · Floating Rate Notes pay interest quarterly (Feb 3, May 3, Aug 3, Nov 3) starting Feb 3, 2027; Fixed Rate Notes pay semi-annually (May 3 and Nov 3) starting May 3, 2027
  • · Floating Rate Notes are not redeemable at the Company's option; Fixed Rate Notes are redeemable in certain circumstances described in the Prospectus Supplement
  • · Notes are senior unsecured obligations ranking equally with other unsecured, unsubordinated debt
  • · Base Indenture dated May 18, 2009 with BNY Mellon as trustee; offering made under Form S-3 (File No. 333-283760) filed December 12, 2024
  • · Maturities range from November 3, 2028 to November 3, 2066, with the longest tranche being a 40-year note
Merck & Co., Inc. 10-Q mixed materiality 9/10

04-11-2026

Merck & Co. reported Q3 2026 sales of $18,085 million, up 4.7% from $17,276 million in Q3 2025, but net income attributable to Merck fell 12.5% to $5,065 million from $5,785 million, and diluted EPS declined to $2.04 from $2.32. Nine-month results swung to a net loss of $510 million versus net income of $15,291 million in the prior-year period, driven by $13,811 million of R&D asset acquisition charges, while nine-month sales rose 4.9% to $50,978 million.

  • · Nine-month 2026 cost of sales rose to $13,482 million from $10,831 million, a 24.5% increase, outpacing sales growth
  • · Nine-month 2026 income tax provision was $1,855 million against pre-tax income of only $1,342 million, reflecting a high effective tax burden on a pre-tax profit base
  • · Q3 2026 Koselugo alliance revenue fell to $13 million from $214 million, a roughly 94% decline, and was the largest drag on alliance revenue
  • · Q3 2026 Lynparza alliance revenue declined 7.1% to $352 million from $379 million
  • · Q3 2026 Adempas/Verquvo alliance revenue was essentially flat, rising 3.3% to $118 million
  • · Total Merck stockholders' equity declined about 14.7% from $52,606 million at December 31, 2025 to $44,893 million, driven by the nine-month net loss and dividends
  • · Long-term debt rose to $49,689 million from $46,750 million while cash fell to $9,550 million from $14,565 million, reflecting acquisition funding
  • · Nine-month 2026 cash outflows for three acquisitions totaled roughly $15,251 million (Cidara, Terns, TARGAN), funded partly by debt issuance of $5,956 million
SHERWIN WILLIAMS CO 4 negative materiality 5/10

04-11-2026

SVP - CLO and Secretary GARCEAU MARY L sold 3,891 Common Stock at $350.42 (~$1.36M). GARCEAU MARY L holds 31,466 shares after the transaction.

  • · SVP - CLO and Secretary GARCEAU MARY L sold 3,891 Common Stock at $350.42 (~$1.36M)
CHEVRON CORP 4 negative materiality 8/10

04-11-2026

President, New Energies GUSTAVSON JEFF B sold 24,439 Common Stock at $230.71 (~$5.64M). 5 transactions reported in total. GUSTAVSON JEFF B holds 3,818 shares after the transaction.

  • · President, New Energies GUSTAVSON JEFF B exercised/converted 8,839 Common Stock at $113.01 (~$999K)
  • · President, New Energies GUSTAVSON JEFF B exercised/converted 15,600 Common Stock at $110.37 (~$1.72M)
  • · President, New Energies GUSTAVSON JEFF B sold 24,439 Common Stock at $230.71 (~$5.64M)
  • · President, New Energies GUSTAVSON JEFF B exercised/converted 8,839 Non-Qualified Stock Option (Right to Buy)
  • · President, New Energies GUSTAVSON JEFF B exercised/converted 15,600 Non-Qualified Stock Option (Right to Buy)
AMAZON COM INC 4 negative materiality 4/10

04-11-2026

CEO Worldwide Amazon Stores Herrington Douglas J sold 1,000 Common Stock, par value $.01 per share at $243.47 (~$243K). Herrington Douglas J holds 473,681 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · CEO Worldwide Amazon Stores Herrington Douglas J sold 1,000 Common Stock, par value $.01 per share at $243.47 (~$243K)
CATERPILLAR INC 10-Q mixed materiality 8/10

04-11-2026

Caterpillar reported Q3 2026 profit of consolidated and affiliated companies of $3,286 Million versus $2,299 Million in Q3 2025, an increase of 42.9% YoY. For the nine months ended September 30, 2026, total sales and revenues rose 21.0% to $58,640 Million from $48,456 Million, and profit attributable to shareholders increased 45.5% to $9,429 Million from $6,482 Million. However, cash and cash equivalents fell 20.6% to $7,929 Million from $9,980 Million since year-end 2025, operating cash flow was driven by a $4,118 Million inventory build and $3,761 Million receivables increase, and total other comprehensive income swung to a loss of $(129) Million for the nine months versus a $748 Million gain a year earlier.

  • · Accounts payable rose 17.9% to $10,573 Million and customer advances rose 60.8% to $5,329 Million, partly offsetting the inventory and receivables build in operating cash flow
  • · Dividends payable fell to zero from $703 Million at year-end 2025, reflecting timing of the dividend declaration cycle
  • · Other liabilities increased 44.4% to $8,919 Million, a notable rise in non-operating obligations
  • · Noncontrolling interests turned negative at $(1) Million versus zero at year-end 2025
  • · Net cash used for financing activities widened to $(7,826) Million from $(4,650) Million, driven by heavier share repurchases of $7,745 Million
  • · Net cash used for investing activities widened to $(4,755) Million from $(2,827) Million, including $893 Million in acquisitions and $1,872 Million in securities purchases
  • · Financial Products long-term debt due after one year increased 7.7% to $21,552 Million

Get daily alerts with 10 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 11 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Dow Jones 30 Stocks SEC Filings

🇺🇸 More from United States

View all →